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Cervical cancer is one of the most common forms of gynecologic cancers both in the 
United States and worldwide. The morbidity and mortality associated with cervical 
cancer has decreased significantly with the development of effective screening for 
cervical cancer.1 However, refugee women in the United States are often impacted by the 
disparities in health care and experience increased risk of adverse health outcomes.  
Literature Review 
Current research finds that refugee women in the United States often receive inadequate 
sexual and reproductive health services, including Pap smears for cervical cancer 
screening. This disparity leads to a higher burden of preventable morbidity and mortality. 
For refugee populations, numerous barriers to access have been identified including 
language, financial, and cultural barriers. Previous studies have identified that refugee 
women may have limited experience with preventative health care or confront cultural 
barriers in accessing sexual and reproductive health services. Further research must be 
done to study barriers to accessing cervical cancer screening among specific populations 
of refugee women.  
Methods and Intervention 
 
 vi 
This study proposes to interview Iraqi, Bhutanese, and Somali refugee women in the 
greater-Boston area in order to better characterize experiences and understanding of 
cervical cancer screening. Investigators will conduct semi-structured interviews to collect 
narrative data, which will then be analyzed using qualitative analysis software to identify 
major themes.  
Conclusion 
This study will seek to characterize perceptions and experiences of cervical cancer 
screening services among female refugees in the greater-Boston area. Limitations of this 
study include lack of generalizability and question-order bias. 
Significance  
The goal of characterizing barriers to access affecting refugee women in the greater-
Boston community is to inform development of more effective public health 
interventions that will be targeted to the specific needs of local refugee populations. 
Efforts to increase uptake of cervical cancer screening services could result in decreased 
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Cervical cancer is the third most common gynecologic cancer in the United States, and 
the most common gynecologic cancer in developing nations.2 In the past, cervical cancer 
was a common cause of death for women in the United States, but the mortality 
associated with this disease has decreased significantly with the development and 
widespread implementation of an effective screening method.1 Cervical cancer is largely 
preventable with adequate screening, so many new or fatal cases of cervical cancer are a 
result of absent or insufficient screening.2 Cervical cancer screening is performed with 
the Papanicolaou test (Pap smear), the gold standard in the United States and worldwide.2 
Although overall mortality rates from cervical cancer have declined, women of color and 
women of low socioeconomic status have a disproportionately high incidence and 
mortality from cervical cancer in the United States.3  
Immigrant and refugee populations are one of the most rapidly growing sectors in 
the United States population, with the foreign-born population increasing from around 10 
million individuals in 1980 to about 38 million individuals in 2007.4 Immigrants and 
refugees face higher rates of inadequate health insurance, poverty, and low 
socioeconomic status, and therefore represent a sector of the population at increased risk 
for adverse health outcomes.4 Refugee women in the United States often exist at the 
crossroads of racial and socioeconomic disparities in health care, thus experiencing 
increased risk for adverse health outcomes. In regards to sexual and reproductive health 
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(SRH) services, refugee women are a particularly vulnerable population who are at risk 
for health disparities due to various barriers to accessing health care services.5  
 
Statement of the Problem 
Cervical cancer is a largely preventable disease for which there are clear, evidence-based 
screening guidelines.6 However, refugee women are a sector of the population who 
receive inadequate sexual and reproductive health services in general, including cervical 
cancer screening. This disparity in screening leads to a disproportionate burden of 
preventable cervical cancer morbidity and mortality.  
 Refugees are defined as individuals who resettle in the United States in order to 
seek physical safety from harm and persecution, with federal and state laws granting 
refugees access to health care services and other basic services needed for survival.7 
Despite the services available to newly resettled refugees, primary care and preventive 
services are underutilized, indicating that there are barriers to access for refugees.8 These 
barriers to access have been investigated, however much of the focus of SRH for 
immigrant and refugee women focuses on prenatal, antenatal, and postnatal care. SRH 
encompasses much more than just care relating to pregnancy. More knowledge is needed 
regarding other aspects of SRH among refugee women, including preventive care such as 
cancer screening. Many of the studies involving refugee health are qualitative which is 
appropriate when trying to understand the personal beliefs, behaviors, and experiences of 
a population. Although the existing literature is informative and provides a useful 
framework for thinking about the health needs of refugee women, it is important to 
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directly evaluate specific populations as different subgroups of refugee women may have 
unique health care experiences, perceptions, and needs.  
 
Hypothesis 
Barriers to access to cervical cancer screening services for refugee women in the greater 
Boston area are likely multifactorial, including lack of familiarity with cervical cancer 
and screening guidelines, language barriers, sociocultural differences, financial barriers, 
and difficulties navigating the U.S. health care system.  
 
Objectives and specific aims 
As the population of the United States grows to encompass more immigrants and 
refugees, it is imperative for the medical community to tailor their approach to care and 
develop understanding of the specific health care needs of minority populations. This 
paper will focus on understanding the health care needs of refugee women, specifically 
Iraqi, Bhutanese, and Somali refugee women in Massachusetts. The goal of fostering 
understanding of these populations is to eventually develop targeted interventions that 
will increase utilization of preventive cervical cancer screening and will decrease 
morbidity and mortality caused by cervical cancer nationwide. This study will utilize 
one-on-one, open-ended interviews with Iraqi, Bhutanese, and Somali women, three 
major ethnic groups of refugees in Massachusetts, in order to identify and categorize 




1. Identify barriers to accessing cervical cancer screening among Iraqi refugees 
in Massachusetts. 
2. Identify barriers to accessing cervical cancer screening among Bhutanese 
refugees in Massachusetts. 
3. Identify barriers to accessing cervical cancer screening among Somali 
refugees in Massachusetts. 
4. Analyze narratives from refugee women to find common themes regarding 






REVIEW OF THE LITERATURE 
Overview 
Cervical cancer is the second most common cancer affecting women,9 and the most 
common gynecologic cancer worldwide.6 Most early cervical cancers are asymptomatic 
and can therefore go undiagnosed in the absence of regular screening.6 The majority of 
cervical cancer mortality is among women in developing countries, where there may be 
limited knowledge of or access to adequate cervical cancer screening services.10 The 
average age of women diagnosed with cervical cancer is 49 years, which is generally 
younger than the age of presentation for other gynecologic malignancies such as 
endometrial or ovarian cancers. Thus, screening must begin earlier in life compared to 
screening for other malignancies such as breast or colon cancer.6 The greatest risk factor 
for developing cervical cancer is the absence of regular screening, which underscores the 
importance of regular screening. Other risk factors include infection with herpes simplex 
virus, sexual activity, increased parity, lower educational levels, obesity, and smoking.6  
 
Epidemiology of cervical cancer 
 
In the United States, cervical cancer incidence has greatly decreased since the 
implementation of widespread cancer screening in the 1960s.11 Within the first decade 
after implementation of routine screening, there was a significant drop in the incidence of 
cervical cancer in the United States. (Figure 1)12 Overall, there has been a 75% reduction 
in cervical cancer incidence and mortality since implementation of screening programs in 
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developed countries.13 However, minority women and women of lower socioeconomic 
status have the highest incidence rates and mortality rates from cervical cancer. 6 This is 
thought to be largely due to financial as well as sociocultural barriers to access to 
screening and subsequent treatment.6 Although this disease is detectable and preventable, 




Figure 1: Effect of cervical cancer screening on the incidence of cervical cancer in 
the United States (Adapted from Wright T, Ferenczy A, Kurman R. Blaustein’s 







Pathophysiology of cervical cancer 
 
The primary etiology of cervical cancer is infection with high-risk strains of human 
papillomavirus (HPV), a double-stranded DNA virus that infects epithelial cells of the 
cervix.9 HPV is a common virus that many individuals contract throughout their lives, 
however, most women are able to clear HPV once infected.14 Over 90% of women who 
are immunocompetent will clear their HPV infection within 2 years.13 If not cleared, 
persistent infections with HPV can lead to cervical dysplasia.6 Cervical dysplasia is 
defined as aberrant or disordered growth of the epithelial cells of the cervix.15 HPV 
strains 16 and 18 are the most commonly implicated subtypes in causing cervical 
dysplasia and subsequent cervical cancer, however around 20 high-risk strains exist.9 
Low-risk strains of HPV are associated with genital warts.15 If HPV infection is 
persistent, it typically takes years for cervical dysplasia to progress to invasive cervical 
cancer.6 HPV infections may be cleared, may persist, or may progress to cervical 
dysplasia and cervical cancer depending on environmental factors, host genetics, and host 




Figure 2: Progression from normal cervical epithelial cell to malignant cell 
(Adapted from Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer 
JI, Corton MM. Cervical Cancer. In: Williams Gynecology. 3rd ed. New York, NY: 
McGraw-Hill Education; 2016. Accessed February 9, 2019).6 
 
Histologically, most cervical cancers are squamous cell carcinomas, however 
some are adenocarcinomas.9 Both types of cervical cancers typically arise in the 
transformation zone of the endocervical canal, the junction between the squamous 
epithelium (ectocervix) and the glandular epithelium (endocervical canal). This 
transitional area may not be fully visualized during gross examination of the cervix 
during pelvic exams, posing a challenge to visually assessing for abnormalities 






Screening for cervical cancer 
 
The Papanicolaou (Pap) smear is the primary screening method for pre-invasive cervical 
dysplasia9 and is the gold standard for screening in the United States and other developed 
countries.10 Pap smears have a 53- to 80-percent sensitivity for detecting high-grade 
cervical lesions.6 However, the dramatic decrease in cervical cancer incidence and death 
rates in countries that perform broad screening is considered to be sufficiently strong 
evidence for the Pap smear as an effective screening tool.9 In some populations, HPV 
testing by polymerase chain reaction (PCR) is utilized to increase the detection of 
cervical pathology.9 It takes years for cervical dysplasia to progress to cervical cancer, so 
periodic screening is relatively effective in identifying early pre-cancerous cells or pre-
invasive cancers.5 
 Although there have been numerous revisions of cervical cancer screening 
guidelines in recent decades, the U.S. Preventive Services Task Force  
(USPSTF) as well as the American College of Obstetricians and Gynecologists (ACOG) 
currently recommend that asymptomatic women of average risk receive Pap smear 
screening starting at age 21, with subsequent screening every 3 years until age 29 if Pap 
smear results are normal.15 The guidelines for women ages 30 to 65 years recommend 
Pap smear screening with HPV co-testing every 5 years if screening is normal and 
negative for HPV infection. Women with multiple sexual partners, a history of sexually 
transmitted infections (STIs), genital warts, or a history of abnormal Pap smears, as well 
as women on immunosuppressive therapy or women who were exposed to 
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diethylstilbestrol in utero are currently advised to be screened annually, consistent with 
previous guidelines.15 For women who are age 65 years and older, providers may 
discontinue Pap smear screening if the patient has had at least 3 negative Pap smears 
consecutively, 2 consecutive negative HPV co-tests within the last 10 years, and provided 
that the woman is of average risk for cervical cancer.15 If women are cytologically 
negative but HPV positive, it is recommended to repeat co-testing at one year or proceed 
with HPV DNA subtyping.13 Women who are pregnant are advised to have a screening 
Pap smear as part of their initial prenatal visit evaluation.13 
 
Clinical presentation, diagnosis, and treatment 
 
Cervical cancer typically has a slow course of progression, and is asymptomatic in early 
stages. Once carcinomas have grown and become invasive, symptoms can include 
intermenstrual or post-coital vaginal spotting, abnormal vaginal discharge, pelvic pain, 
and pain with intercourse.9 As the malignancy grows, vaginal spotting and bleeding 
typically worsens.6 The most common objective physical exam finding in women with 
symptomatic cervical cancer is a visible malignancy on the ectocervix, and such lesions 
can be biopsied directly.9 
While the Pap smear is an effective screening test, it cannot be diagnostic for 
cervical cancer.15 An abnormal Pap smear merely indicates the need for additional 
evaluation. HPV testing can also be performed in conjunction with the Pap test to identify 
infection with high-risk strains of the virus, however presence of a high-risk strain of 
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HPV is also not diagnostic for cervical cancer.15 A finding of abnormal cytology 
indicates a need for further evaluation with a colposcopy, endocervical curettage, cervical 
biopsy, or a loop electrosurgical excision procedure (LEEP).15 Colposcopy is a procedure 
that involves direct visual examination of the cervix using a binocular microscope.15 
Chemical agents are utilized to enhance visualization of abnormal cells during this 
procedure.15 This tool allows providers to see areas of dysplasia or other abnormalities on 
the ectocervix. LEEP is a technique that employs a low-voltage current to excise areas of 
cervical dysplasia and obtain biopsies of the cervix.15 Cytologic and histologic specimens 
are described as either low-grade squamous intraepithelial lesions (LSIL) indicating mild 
dysplasia or high-grade squamous intraepithelial lesions (HSIL) indicating moderate to 
severe dysplasia or carcinoma-in-situ .15 Staging of cervical cancer is based on the level 






Figure 3: Stages of dysplasia in cervical cancer cells (Adapted from NCI Dictionary 
of Cancer Terms. National Cancer Institute. 
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/lsil).16  
 
According to the 2013 American Society for Colposcopy and Cervical Pathology 
(ASCCP) guidelines, when a woman is diagnosed with LSIL with a negative HPV test, 
expectant management with repeat cervical cytology and possible colposcopy at one year 
is appropriate.17 Women with LSIL on cytology with a positive HPV test proceed with 
colposcopy for further evaluation.17 All women with cytology results that cannot exclude 
HSIL or are confirmed HSIL proceed with either colposcopy with endocervical 
assessment or proceed directly to LEEP.17 Guidelines for subsequent testing after 
colposcopy/LEEP and recommendations for evaluation of other findings on cytology are 
nuanced and will not be detailed in this review.   
Treatments for malignant lesions utilizes ablative therapies, if invasive disease 
has been excluded.13 Ablative therapies include laser ablation or cryotherapy.13 If 
invasive disease has not been excluded, excisional treatment such as LEEP, laser cone 
excision, and cold knife conization are preferred to allow for further histologic study to 
determine if treatment has adequately targeted the area of malignancy.13 Women with 
extensive or late-stage disease may proceed directly to radical hysterectomy with pelvic 
lymph node dissection.6 Adjuvant chemotherapy or radiation therapy may also be 
considered based on staging and histologic factors of the disease.6 
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Once treated, there is an 80% success rate regardless of which treatment 
technique is utilized.13 Most treatment failures are diagnosed within a few years of the 
initial therapy on subsequent follow-up cytology, cervical sampling, or colposcopy.13 
Treatment goals include reducing symptoms such as spotting and abnormal discharge, 




 HPV vaccines approved by the U.S. Food and Drug Administration (FDA) 
include Gardasil, a quadrivalent vaccine, Gardasil 9, a nine-valent vaccine, and Cervarix, 
a bivalent vaccine.13 These vaccines provide inoculation against multiple strains of HPV, 
including the high-risk oncogenic strains 16 and 18.9 The HPV vaccines have been shown 
to be 93-100% effective in preventing HSIL.13 Currently, the Centers for Disease Control 
and Prevention recommend that these vaccines be offered to all children as young as 9 
years old and should extend to females until age 26 and males until age 21. Vaccination 
is a primary prevention strategy can protect women from HPV infection and resulting 








Overview of refugee women’s health 
 
The  Office of the United Nations High Commissioner for Refugees (UNHCR) 
defines a refugee as a person who is outside of the country of his or her nationality due to 
a well-founded fear of being persecuted due to race, religion, nationality, membership of 
a social or political group, and who is unwilling or unable to return to the country of his 
or her nationality.18 Asylum-seekers are defined as individuals who are seeking 
international protection, but whose claim has not yet been evaluated or decided upon by 
the host country.18 According to the UNHCR 2017 Global Report, there are at least 68.5 
million forcibly displaced people worldwide, encompassing internally displaced people, 
refugees, and asylum-seekers. This report states that there were 392,296 refugees and 
701,455 asylum-seekers in North America and the Caribbean as of December 2017.7  
According to the Massachusetts Department of Public Health (DPH), over 12,000 
refugees have resettled in Massachusetts between the years of 2011-2016 (Table 1).19 The 
largest groups of refugees in Massachusetts during this period have immigrated from 
Iraq, Bhutan, and Somalia.20 Resettlement in a new country provides refugees with 
physically safe living conditions; however, refugees face other challenges relating to the 
resettlement process. Some of these challenges can include language barriers, 
acculturation difficulties, social isolation, and mourning of the loss of their native 
countries and cultures.21 The Massachusetts Office for Refugees and Immigrants provides 
services such as case management, up to 8 months of cash assistance, employment 
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services, health assessments, and 8 months of health insurance coverage for refugees who 
are ineligible for Medicaid/MassHealth.22 
 
Table 1. Refugee Arrivals in Massachusetts by Country of Origin (adapted from 
Massachusetts DPH, 201620 and Massachusetts DPH, 2017.)19  
 2011 2012 2013 2014 2015 2016 Total: 
Iraq 321 645 767 697 383 356 3,169 
Bhutan 515 517 329 251 178 254 2,044 
Somalia 141 238 249 332 356 232 1,548 
 
 
Many displaced people suffer from a variety of acute and chronic diseases, which 
may go undiagnosed or untreated during periods of instability in native countries, during 
time spent in refugee camps with limited resources, and after resettlement due to barriers 
in accessing health care in new host countries.23  
Federal refugee resettlement programs offer aid for refugees upon arrival in the 
United States.23 Under the Refugee Act of 1980, the United States government provides 
medical, financial, and legal support to refugees.21 Refugees in Massachusetts are 
universally eligible for health insurance that covers basic medical needs including 
primary care and preventive services.24 Refugee Medical Assistance is health insurance 
that is available to newly-resettled refugees for up to 8 months after arrival, however 
given the burden of chronic diseases, refugees are still at risk for being inadequately 
insured and having adverse health outcomes.21  
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In the United States, newly arrived refugees undergo a domestic health 
assessment after arrival. These intake health assessments are typically focused on 
diagnosing and treating infectious diseases, and are less likely to focus on diagnosis and 
management of chronic disease, mental health issues, or on preventative health care.23 
Despite this initial health assessment, refugees experience limited access to health care 
services due to difficulty navigating the health care system or due to a range of other 
barriers.21  
The Canadian Research Institute for the Advancement of Women (CRIAW) has 
reported that an average of seventy-five percent of displaced people worldwide are 
women and children.8 Refugee women are a population that are particularly vulnerable to 
adverse physical and mental health outcomes relating to displacement and resettlement.8 
Many refugee women migrate from countries with high rates of cervical cancer incidence 
and mortality, with disparities in access to screening services continuing to persist after 
resettlement in the United States.25  
 
Existing research 
Numerous studies have evaluated the particular health care needs and outcomes for 
refugee and immigrant populations both in the United States and in other developed 
countries. There is existing research evaluating the sexual and reproductive health of 
refugee women in the United States, as well as in other host countries around the world. 
Much of this research has focused on the utilization of prenatal, antenatal, and postnatal 
care. In 2013, the CDC recommended that all refugee woman receive cervical cancer 
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screening after settling in the United States, however there are common barriers to 
accessing care for refugee women. These barriers include lack of knowledge of 
preventive care or primary care services, language barriers, financial barriers, and cultural 
barriers.25  
One article by Lamb and Smith26 discussed the problems with health care access 
that refugees experience when settling in developed countries such as Australia. This 
article noted that refugees are a particularly vulnerable population and may have specific 
health care needs related to their experiences of conflict, trauma, and forced exile from 
their home countries. If refugees are fleeing from countries with political instability or 
conflict, they may have experienced psychological trauma, physical harm, and poor 
access to health care services. The authors propose that possible barriers to accessing care 
for newly resettled refugees could include language barriers, financial constraints, limited 
trust in health care providers, and cultural differences. The authors note that health care 
providers can attempt to increase refugees’ utilization of services through community 
outreach and educational campaigns, utilizing workers who are familiar with both 
cultures, and by collocating health care services with other services that refugees 
commonly use.  
A qualitative study by Morris et al.23 sought to gather information on health issues 
among refugees in San Diego County in order to assess the health care needs of refugees 
who had been settled in the U.S. for at least 1 year. To gather a wide variety of 
perspectives on refugee health issues, this study carried out 40 in-depth interviews with 
providers, aid organization employees, and recent refugees residing in the U.S. for at 
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least 1 year. The researchers noted a variety of barriers to accessing health care including 
language, transportation, logistical, financial barriers and difficulties with acculturation. 
Acculturation was defined as “the merging and adoption of behavior patterns between 
cultures as a result of prolonged contact.”23 This study noted that refugees’ native 
cultures had a direct impact on their behaviors regarding preventative health care, 
expectations of health care in their host country, and stigma surrounding health 
conditions, particularly mental health conditions. The authors concluded that providers 
must focus on providing culturally tailored care to refugee populations.    
Salman and Resick8 carried out a qualitative descriptive study to gather data about 
the health of resettled Iraqi refugee women in the United States in order to inform how to 
provide culturally competent care to this population of women. They recruited 12 women 
between the ages of 21 and 67 years old who resettled in the United States after 2003. 
They conducted individual interviews with the goal of learning about women’s 
description of health as a concept, assessment of their own health status in the context of 
resettling in the U.S., and their health experiences. Participants described health as a 
highly valued gift that many attributed to their strong faith and devotion to their religion. 
Women also described health as the absence of physical symptoms, indicating a potential 
lack of experience with preventive medicine. Many participants considered safety and 
security as high priorities and aspects of their overall health. This theme highlights that 
many refugee women have experienced trauma, violence, war, and instability in their 
native countries, and how such experiences directly influence their concepts of health and 
wellbeing. Participants described challenges with utilizing the health care system in the 
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U.S., and cited inexperience with health insurance, primary care, and navigating a 
complex and foreign health care system. Finally, participants noted language, cultural, 
and financial barriers to accessing health care services. Although the sample size of this 
study was small, the descriptive narratives provide insight into refugee women’s 
experiences with health care.  
Fink et al.5 discussed refugee health through the lens of women’s health issues. 
The authors note that women’s health encompasses a broad spectrum of sexual and 
reproductive health issues. They discussed pre-migratory challenges including limited 
access to women’s health care services in war- or conflict-affected native countries. 
Migratory stressors include living in refugee camps in which women may experience 
physical or sexual violence, as well as post-migratory stressors of resettlement, which can 
include poverty, social isolation, and acculturation challenges. Refugee women may 
underutilize primary and preventive care services due to lack of these services in native 
countries or unfamiliarity with the health care system of new host-countries. Regarding 
pelvic exams, the authors noted that these exams may be stressful or re-traumatizing for 
women who have histories of sexual violence, physical abuse, or history of female genital 
circumcision. These exams may also feel culturally inappropriate for refugee women who 
come from cultures that consider gynecologic exams immodest. The authors stated that 
same refugee women may have never had access to sexual and reproductive health 
services, including Pap smears and mammography, in their native countries. They noted 
that immigrant and refugee women tend to be under-screened in host countries due to 
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numerous barriers to access including lack of knowledge about cervical cancer and lack 
of familiarity with preventive care in general.  
Haworth et al.10 carried out a study to assess the knowledge, perceptions, and 
behaviors of cervical cancer screening among the Bhutanese refugee population in 
Omaha, Nebraska. The researchers provided 42 participating women with self-
administered questionnaires and utilized focus groups to gather information. Women 
from the Bhutanese community were involved in recruiting participants. The majority of 
participating women reported resettling in the United States within the previous 2 years. 
Questionnaires and focus groups sought to determine women’s knowledge and perception 
of cervical cancer, the role of screening, women’s susceptibility to cervical cancer, and 
perceived barriers to screening. The study found that there was a lack of knowledge about 
cervical cancer and about screening recommendations, with only about 20% of 
participants having ever heard of Pap smears and even fewer ever undergoing a Pap 
smear. Women were also noted to have a low perceived susceptibility to cervical cancer. 
Researchers observed that women were interested in having community health workers 
who could facilitate cervical cancer educational initiatives. This study determined that 
some barriers to cervical cancer screening for participants included lack of knowledge, 
language, transportation, financial concerns, lack of trust in providers, cultural 
differences, and difficulty navigating the health system. This study also further 
highlighted that decreased utilization of cervical cancer screening is one clear health 
disparity affecting this population of refugee women.  
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Ornelas et al.25 studied the barriers to cervical cancer screening in 40 Karen-
Burmese and Nepali-Bhutanese women aged 21 to 65 years old in the United States. This 
study noted that refugee women face a myriad of barriers to screening that include 
limited knowledge of cervical cancer, poor understanding of screening recommendations, 
cultural barriers to access, and language barriers. Participants in this study noted a lack of 
understanding of female anatomy, cervical cancer screening and prevention, and lack of 
familiarity with Pap smears. Participants also mentioned that limited English proficiency, 
lack of insurance, and difficulties with cost and transportation all affected their ability to 
access health care services. This study piloted an educational video to promote screening 
among these refugee groups. Educational videos were narrative-based, featuring multi-
generational characters to whom participants could relate, and were culturally tailored by 
methods such as using appropriate language translation, displaying photos from 
participants’ countries of origin, highlighting native health practices, and playing 
traditional music from participants’ native countries. Participants watched the videos at 
home with a health educator, and were given a pre-test and post-test evaluation. The 
authors found that women had increased knowledge of cervical cancer, screening 
guidelines, and greater intentions to obtain screening. Despite a relatively small sample 
size and involvement of two specific refugee communities for whom the results may not 
be generalizable, this study found that culturally sensitive educational materials and 
outreach from community health workers could increase knowledge and potentially 
influence behaviors regarding cervical cancer screening.  
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 Piwowarczyk et al. evaluated an educational program entitled the UJAMBO 
project for Congolese and Somali immigrant and refugee women in Boston, 
Massachusetts.27 Participants were invited to attend workshops that involved watching a 
culturally and linguistically tailored DVD that imparted information about women’s 
health services including mammography, Pap smears, and other relevant services. These 
women completed self-administered surveys in order to provide pre- and post-test data. 
Prior to viewing the informational DVD, one-third of the participants reported having a 
lack of knowledge of Pap smears and other SRH services. Post-test analysis showed that 
these culturally sensitive education workshops improved knowledge of preventative SRH 
services and increased women’s intentions to receive mammograms and Pap smears. As 
was noted in this study, women from a variety of ethnocultural groups could potentially 
benefit from access to culturally tailored information regarding SRH.   
Mehta et al. performed a secondary analysis of the UJAMBO program.28 In this 
study, the authors noted that immigrant women in general are less likely to have 
undergone a Pap smear in the last year and less likely to regularly access health care 
services. This secondary analysis utilized focus groups to evaluate behaviors regarding 
gynecologic care as well as barriers to access in Congolese and Somali immigrant 
communities. Thirty-one Somali and Congolese women in six focus groups were 
interviewed. One theme from these interviews was that Somali and Congolese women 
typically sought SRH care in the context of pregnancies, consistent with existing research 
regarding SRH care utilization in other refugee populations. They described a culture of 
seeking health care when pregnant or unwell, but not when they were asymptomatic or 
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otherwise well. Women endorsed the sentiment that one should seek health care when 
negative symptoms such as pain are present. This lack of familiarity with preventative 
care was seen less among younger participants. Another important theme that arose in 
these focus groups was that both Congolese and Somali women strongly preferred to 
receive SRH care from female providers. Women endorsed feelings of shame or 
discomfort with seeing male providers, as well as a desire to preserve modesty and avoid 
exposure of their female anatomy. Some women, more commonly Congolese 
participants, also noted that experiences of sexual violence and trauma played a role in 
their desire to see female providers. One additional theme that arose from this focus 
group analysis was the stigma of seeking gynecologic care. Women from all age groups 
noted concerns that family members, husbands, other community members would 
criticize women for seeking out gynecologic care. Particularly, unmarried women 
reported that seeking out gynecologic health care services may imply that a woman was 
engaging in pre-marital intercourse, which was stated to be culturally taboo. This desire 
to adhere to cultural norm was noted to be an important sociocultural barrier to seeking 
care.  Mehta et al. succinctly highlight numerous barriers to seeking SRH services among 
immigrant and refugee women.28 
 Metusela et al.29 performed a qualitative study examining the SRH experiences 
among migrant and refugee women who had recently resettled in Sydney, Australia and 
Vancouver, Canada. Participants were originally from multiple countries including Iraq, 
Afghanistan, Somalia, Sudan, India, Sri Lanka, and others. Researchers carried out 84 
individual interviews as well as 16 focus groups involving an additional 85 participants. 
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Most of these interviews were conducted with the use of translator services and 
questioning focused on women’s experiences with reproduction, sexuality, and SRH 
experiences and practices. Thematic analysis of the data from these interviews was used 
to identify major themes in refugee women’s experiences with SRH services. The authors 
noted that for many refugee women, SRH needs were often lower priorities compared to 
other needs after resettlement with their main priorities being safety and security for 
women and their families. The authors mention that SRH topics are considered taboo in 
more conservative cultures. Patriarchal values in many societies may influence women’s 
desire or ability to seek out SRH services. Lack of knowledge of SRH issues and 
inadequate utilization of SRH services can lead to a variety of adverse health outcomes 
for refugee women, including traumatic experiences of menarche, discomfort or pain 
with intercourse, STIs, undesired pregnancy, and delayed diagnosis of gynecologic 
malignancies. All of these adverse outcomes would affect women’s overall quality of life. 
Across all cultural groups, women reported a lack of knowledge regarding SRH, 
including menstruation, fertility, menopause, contraception, STIs, cervical cancer 
screening, HPV testing, and HPV vaccination. Women described menstruation as being a 
shameful topic and stated that talking about intercourse was forbidden in their cultures. 
Women reported stigma around engaging in premarital intercourse, and stated that 
premarital sexual activity could result in social exclusion. One theme regarding cervical 
cancer screening was that it was immodest and a threat to a woman’s virginity. This study 
identified many common themes regarding SRH knowledge and practices among a broad 
range of cultural groups. In this study, it was also noted that many participants showed an 
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interest in increasing their knowledge of SRH topics. One particular strength of this study 
was its inclusion of women from numerous cultural and ethnic groups, which allowed for 
comparison and elucidation of cross-cultural experiences regarding SRH.  
 Overall, the body of existing research has shown that refugees, in particular 
refugee women, are at risk of poor utilization of preventive health care services. The 
reasons for this are multifactorial with commonly identified barriers that include 
language, financial, sociocultural barriers, and lack of knowledge about SRH guidelines 
and practices. Refugee women represent a vulnerable sector of the population and there is 
evidence to support that these women experience significant health disparities in regards 





This study will be a qualitative study that will utilize open-ended, in-depth interviews 
with individual Iraqi, Bhutanese, and Somali refugee women from the greater Boston 
area. This study will seek to define and understand refugee women’s knowledge of and 
experience with cervical cancer screening. Information will be gathered from one-on-one 
interviews. Interviews will be conducted in English or participants’ native languages per 
participant preference. The goal of this study will be to characterize opinion and 
experience of cervical cancer screening among these specific refugee populations. 
Investigators will utilize a grounded theory approach, which is a method of qualitative 
research that draws theories from a pool of collected narrative data.30 These theories will 
aim to better characterize refugee women’s experiences with cervical cancer screening 
and potentially identify barriers to access.  
 
Study population and sampling 
Study subjects will be recruited from Boston Medical Center’s Refugee Women’s Health 
Clinic. Participants will be assessed based on specific inclusion and exclusion criteria 







Table 2. Inclusion Criteria for Participants.  
 
If patients meet the defined inclusion criteria, they may be recruited to participate 
in an in-person interview.  
In this qualitative study, the sample size will be based on theoretical saturation, 
meaning that an adequate sample size is reached when continued data collection no 
longer provides new or additional themes.31 For this study, a minimum sample size of 30 
participants will be established with the goal of reaching theoretic saturation.  
 
Interview Structure 
This qualitative study will consist of one-on-one, open-ended interviews conducted to 
record information about the study population’s knowledge of and experiences with 
cervical cancer screening. Interviews will be conducted on-site at Boston Medical Center 
or at participants’ homes based on preference and pending interpreter availability. 
Consent forms will be provided to all participants and interviews will be conducted once 
consent is obtained. Interviews will be conducted by a trained investigator. In-person 
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language interpreters will be provided per participant preferences. If no in-person 
interpreters are available, telephone interpreters may be utilized.  
Investigators will utilize a demographic questionnaire to collect participant 
information including age, nationality, language, education level, socioeconomic status 
defined by household income, and refugee or asylee status. This information will be 
placed into a database which will also contain a code to identify participants. Participant 
interview transcripts will be labeled with only this identifying code to ensure 
confidentiality. 
Investigators will then conduct interviews using a standardized set of questions, 
however the interviews will be informal and semi-structured; questions will be open-
ended to allow participants to provide personalized narratives. As a qualitative study, the 
goal of these interviews will be to gather a variety of narratives in order to better 
understand the participant population in regards to knowledge and opinions of cervical 
cancer screening.  
  
This study’s interviews will seek to address the following topics: 
a. Understanding of cervical cancer as a disease 
b. Knowledge of symptoms of cervical cancer 
c. Understanding of HPV as a causative agent of cervical cancer 
d. Understanding of methods of transmission of HPV 
e. Knowledge of HPV vaccine 
f. Past experiences with Pap smears 
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g. Past experiences with HPV testing  
h. Cultural perceptions of cervical cancer screening 
i. Barriers to obtaining screening  
  
Recruitment 
Study candidates will be continuously recruited from Boston Medical Center’s Refugee 
Women’s Health Clinic. All female patients between the ages of 21 and 65 years old who 
are identified to be of Iraqi, Bhutanese, or Somali nationality and attend the BMC 
Refugee Women’s Health Clinic from January 1, 2020 to June 30, 2020 will be invited to 
participate. Initial screening for these patients will be done in the form of a printed survey 
that will ask patients about their age, nationality, and whether or not they relocated to the 
United States as refugees or asylees. A definition of refugee and asylee status will be 
provided on this survey. If candidates meet these criteria according to survey responses 
and indicate a willingness to participate, they will be contacted by investigators by 
telephone for additional screening. Potential participants will be provided with an 
overview of the goals of this study. If candidates meet inclusion criteria and provide 
consent, they will be invited to participate in this study.  
 
Data collection 
Investigators and in-person interpreters will conduct interviews with participants for 
around 60 minutes. Interviews will be recorded and later transcribed with assistance from 
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interpreters. Information regarding patient demographics such as age, education level, 
refugee or asylee status, and socioeconomic status will also be collected. 
 
Data analysis 
Investigators will analyze this narrative data as it is being collected. Transcripts will be 
reviewed and coded by investigators. The goal of reviewing transcripts will be to identify 
themes in participants’ knowledge of or opinions regarding cervical cancer and cervical 
cancer screening. The process of analyzing this qualitative data as it is collected will 
allow major themes and commonalities to arise. The data will be coded with an inductive 
analytic approach such that codes and themes will arise from the narratives. Transcripts 
will be double-coded so multiple researchers will independently assign codes to the data.  
ATLAS.ti software will be used for data organization and analysis. ATLAS.ti is a 
program that allow researchers to code and annotate findings from primary qualitative 
data. Themes that arise frequently during interviews will be noted and used to guide 
subsequent interview sessions.  
 
Timeline and resources 
Investigators will conduct interviews and complete data collection and analysis. For this 
study, investigators will require access to BMC’s interpreter services and appropriate 
compensation will be provided to interpreters. Investigators will develop a relationship 
with providers affiliated with BMC’s Refugee Women’s Health Clinic in order to 
facilitate participant recruitment. The recruitment and interview period will occur over 
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the course of 6 months, from January 1, 2020 to June 30, 2020. Coding and data analysis 
will occur throughout the interview period and will continue for a three month period 
from July 1, 2020 to September 30, 2020. Facilities in the Boston University Medical 
Campus will be required for on-site interviews and ATLAS.ti software will be required 
for data analysis. 
 
Institutional Review Board 
This study will be submitted to the Boston University Medical Campus IRB for expedited 
review under the 45 CFR 46.102 criteria, given that this proposed study will provide no 





The results of this study will evaluate the specific barriers faced by Iraqi, Bhutanese, and 
Somali refugee women in the greater Boston area. Although there is a wide breadth of 
literature that examines sexual and reproductive health service uptake among refugee 
women, further research is needed on specific refugee populations. This study will allow 
further understanding of barriers to accessing care among major refugee populations 
within the Boston Medical Center patient population. The qualitative nature of this study 
will preserve the complexities of participants’ experiences while allowing for major 
themes and commonalities to arise. The results of this study will help to inform future 
public health initiatives to increase uptake of preventative sexual health services.   
 Limitations of this study include lack of generalizability and question-order bias.  
Because this study will focus on three major refugee populations in the greater-Boston 
area, the findings of this study may not be generalizable to other refugee populations or 
the greater population in the United States. Because of the small sample size, findings 
also may not be fully generalizable to the populations included in the study, but will seek 
to characterize nuances in the data. Additionally, participants will be recruited from a 
clinical facility and will already have some engagement with the health care system. 
Therefore, the perceptions of women in this study may not accurately reflect the broader 
perceptions of women who are not currently engaged with health care services. This 
study will have question-order bias, as participants’ responses to interview questions will 
likely influence subsequent questions that are posed by the investigator. This is to be 
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expected in semi-structured, open-ended interviews where the goal is to capture a 
personal narrative.  
 
Summary 
Immigrants and refugees are a rapidly growing sector in the United States population.4 
Female refugees face significant disparities in health care and an increased burden of 
adverse health outcomes. This is due to numerous barriers to accessing health care 
services including language, financial, and cultural barriers. Research shows that refugee 
women tend to have lower rates of utilization of preventative sexual health services in the 
United States.5 
 Public health campaigns to provide culturally-tailored education to refugee 
women may help to increase the uptake of cervical cancer screening services among the 
Boston Medical Center patient population. However, before such campaigns can be 
designed, it is critical to evaluate refugee women’s perceptions and experiences of 
cervical cancer screening. The findings of this study may inform future development of 
targeted interventions to increase uptake of preventive cervical cancer screening, which 
will subsequently decrease cervical cancer morbidity and mortality among refugee 
women in this community. 
The current body of research lacks a clear understanding of the refugee groups 
who seek care at BMC’s Refugee Women’s Health Clinic. It is important to gather 
specific knowledge about the refugee groups that are most prevalent in the greater Boston 
area. This study aims to utilize interviews with women from three major populations of 
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refugees in the Boston area in order to develop a broad understanding of this patient 
population’s beliefs and experiences regarding cervical cancer screening and preventative 
sexual health care. As individual narratives are collected, data will be analyzed for major 
themes regarding cervical cancer screening. This knowledge will allow for the 
development of more targeted and personalized interventions to increase cervical cancer 
screening rates.  
  
Clinical and/or public health significance 
Cervical cancer can be fatal if not adequately screened for and treated. Although the 
morbidity and mortality associated with cervical cancer in the United States has 
decreased due to comprehensive guidelines for screening and treatments.1 However, 
refugee women in the United States are often affected by both racial and socioeconomic 
disparities in health care, and therefore experience a disproportionate burden of adverse 
health outcomes. Numerous barriers have been identified that may contribute to this, 
including language, financial, and cultural barriers.  
Studies have demonstrated that migrant women often experience lack of exposure 
to preventative health care services or cultural taboo surrounding sexual health services, 
depending on nationality. Increasing uptake of cervical cancer screening and preventative 
sexual health care will decrease the overall morbidity and mortality due to cervical cancer 
among refugee women. This study will improve understanding of refugee women’s 
beliefs and experiences of cervical cancer screening, and this knowledge can be used to 
fuel future campaigns aimed at addressing barriers to cervical cancer screening.  
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